Alpha 2.0
Login Register
» Authors » Harry Genant

Harry Genant

Explore the profile of Harry Genant including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 1900
Followers 0
Related Specialties
Rheumatology
Orthopedics
General Medicine
Top 10 Co-Authors
Charles Peterfy
Mikkel Ostergaard
Paul Bird
Marissa Lassere
Paul Emery
Philip OConnor
Bo Ejbjerg
Fiona McQueen
Philip G Conaghan
John Edmonds
Published In
J Rheumatol
Ann Rheum Dis
J Bone Miner Res
J Clin Densitom
Curr Med Res Opin
Affiliations
Soon will be listed here.
Recent Articles
1.
Identifying the preferable rheumatoid arthritis subgroups for intervention with the anti-RANKL antibody denosumab to reduce progression of joint destruction
Tanaka Y, Soen S, Ishiguro N, Yamanaka H, Yoneda T, Tanaka S, et al.
RMD Open . 2020 Aug; 6(2). PMID: 32732353
Objectives: To clarify which rheumatoid arthritis (RA) patients benefit most from the anti-receptor activator of nuclear factor-κB ligand antibody denosumab to reduce the progression of joint destruction. Methods: We pooled...
2.
High Kellgren-Lawrence Grade and Bone Marrow Lesions Predict Worsening Rates of Radiographic Joint Space Narrowing; The SEKOIA Study
Edwards M, Parsons C, Bruyere O, Petit Dop F, Chapurlat R, Roemer F, et al.
J Rheumatol . 2016 Jan; 43(3):657-65. PMID: 26773120
Objective: Determinants of radiographic progression in osteoarthritis (OA) are poorly understood. We investigated which features on baseline magnetic resonance imaging (MRI) acted as predictors of change in joint space width...
3.
Relationship Between Vertebral Fracture Burden, Height Loss, and Pulmonary Function in Postmenopausal Women With Osteoporosis
Krege J, Kendler D, Krohn K, Genant H, Alam J, Berclaz P, et al.
J Clin Densitom . 2015 Apr; 18(4):506-11. PMID: 25824332
The purpose of this analysis was to assess the association of osteoporosis-related vertebral fracture burden and pulmonary function. This study also examined the relationship between vertebral fracture burden and height...
4.
Maintenance of remission following 2 years of standard treatment then dose reduction with abatacept in patients with early rheumatoid arthritis and poor prognosis
Westhovens R, Robles M, Ximenes A, Wollenhaupt J, Durez P, Gomez-Reino J, et al.
Ann Rheum Dis . 2015 Jan; 74(3):564-8. PMID: 25550337
Objectives: To evaluate maintenance of response while reducing intravenous abatacept dose from ~10 mg/kg to ~5 mg/kg in patients with early rheumatoid arthritis (RA) who achieved disease activity score (DAS)28...
5.
Update on the OMERACT magnetic resonance imaging task force: research and future directions
Conaghan P, McQueen F, Bird P, Peterfy C, Haavardsholm E, Gandjbakhch F, et al.
J Rheumatol . 2013 Dec; 41(2):383-5. PMID: 24293579
Magnetic resonance imaging (MRI) provides an important biomarker across a range of rheumatological diseases. At the Outcome Measures in Rheumatology (OMERACT) 11 meeting, the MRI task force continued its work...
6.
Iterative development and reliability of the OMERACT hand osteoarthritis MRI scoring system
Haugen I, Ostergaard M, Eshed I, McQueen F, Bird P, Gandjbakhch F, et al.
J Rheumatol . 2013 Dec; 41(2):386-91. PMID: 24293570
Objective: To develop and test the interreader reliability of the OMERACT Hand Osteoarthritis Magnetic Resonance Scoring System (HOAMRIS) for assessment of structural and inflammatory hand OA features in the interphalangeal...
7.
Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial
Reginster J, Badurski J, Bellamy N, Bensen W, Chapurlat R, Chevalier X, et al.
Ann Rheum Dis . 2012 Nov; 72(2):179-86. PMID: 23117245
Background: Strontium ranelate is currently used for osteoporosis. The international, double-blind, randomised, placebo-controlled Strontium ranelate Efficacy in Knee OsteoarthrItis triAl evaluated its effect on radiological progression of knee osteoarthritis. Methods:...
8.
Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial
Cooper C, Reginster J, Chapurlat R, Christiansen C, Genant H, Bellamy N, et al.
Curr Med Res Opin . 2011 Dec; 28(2):231-9. PMID: 22148897
Objective: The osteoporosis drug strontium ranelate dissociates bone remodelling processes. It also inhibits subchondral bone resorption and stimulates cartilage matrix formation in vitro. Exploratory studies in the osteoporosis trials report...
9.
Biochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities
Karsdal M, Woodworth T, Henriksen K, Maksymowych W, Genant H, Vergnaud P, et al.
Arthritis Res Ther . 2011 May; 13(2):215. PMID: 21539724
Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease associated with potentially debilitating joint inflammation, as well as altered skeletal bone metabolism and co-morbid conditions. Early diagnosis and aggressive treatment...
10.
The OMERACT psoriatic arthritis magnetic resonance imaging scoring system (PsAMRIS): definitions of key pathologies, suggested MRI sequences, and preliminary scoring system for PsA Hands
Ostergaard M, McQueen F, Wiell C, Bird P, Boyesen P, Ejbjerg B, et al.
J Rheumatol . 2009 Aug; 36(8):1816-24. PMID: 19671819
This article describes a preliminary OMERACT psoriatic arthritis magnetic resonance image scoring system (PsAMRIS) for evaluation of inflammatory and destructive changes in PsA hands, which was developed by the international...